DK1696911T3 - Intranasale sammensætninger - Google Patents

Intranasale sammensætninger

Info

Publication number
DK1696911T3
DK1696911T3 DK04798713.6T DK04798713T DK1696911T3 DK 1696911 T3 DK1696911 T3 DK 1696911T3 DK 04798713 T DK04798713 T DK 04798713T DK 1696911 T3 DK1696911 T3 DK 1696911T3
Authority
DK
Denmark
Prior art keywords
compositions
salt
intranasal compositions
derivative
chitosan
Prior art date
Application number
DK04798713.6T
Other languages
English (en)
Inventor
Alan Smith
Peter James Watts
Jonathan Castile
Original Assignee
Archimedes Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimedes Dev Ltd filed Critical Archimedes Dev Ltd
Application granted granted Critical
Publication of DK1696911T3 publication Critical patent/DK1696911T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK04798713.6T 2003-12-05 2004-11-30 Intranasale sammensætninger DK1696911T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0328186.2A GB0328186D0 (en) 2003-12-05 2003-12-05 Intranasal compositions
PCT/GB2004/005043 WO2005056008A1 (en) 2003-12-05 2004-11-30 Intranasal compositions

Publications (1)

Publication Number Publication Date
DK1696911T3 true DK1696911T3 (da) 2010-06-28

Family

ID=29764615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04798713.6T DK1696911T3 (da) 2003-12-05 2004-11-30 Intranasale sammensætninger

Country Status (26)

Country Link
US (1) US7947257B2 (da)
EP (1) EP1696911B1 (da)
JP (1) JP5103018B2 (da)
KR (1) KR101194593B1 (da)
CN (2) CN1901905A (da)
AT (1) ATE460932T1 (da)
AU (1) AU2004296586B2 (da)
BR (1) BRPI0417350A2 (da)
CA (1) CA2548559C (da)
CY (1) CY1110664T1 (da)
DE (1) DE602004026107D1 (da)
DK (1) DK1696911T3 (da)
ES (1) ES2357607T3 (da)
GB (1) GB0328186D0 (da)
HR (1) HRP20100343T1 (da)
IL (1) IL176132A (da)
ME (1) ME01070B (da)
MX (1) MXPA06006239A (da)
NO (1) NO335348B1 (da)
NZ (1) NZ547848A (da)
PL (1) PL1696911T3 (da)
PT (1) PT1696911E (da)
RS (1) RS51251B (da)
SI (1) SI1696911T1 (da)
WO (1) WO2005056008A1 (da)
ZA (1) ZA200604553B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
JP4922762B2 (ja) 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US7868016B2 (en) * 2005-07-13 2011-01-11 Baxter International Inc. Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
WO2007035008A1 (en) * 2005-09-23 2007-03-29 Amphenol Phoenix Co., Ltd. Sliding type opening and closing apparatus for use in portable telephone
SI1933809T1 (sl) * 2005-10-11 2012-08-31 Yissum Res Dev Co Sestavki za mazalno dajanje
JP5415769B2 (ja) * 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
EP2429495A4 (en) * 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
KR101368587B1 (ko) 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
CN107921033B (zh) * 2015-04-08 2021-01-01 美治医药科技有限公司 供鼻内给药的格拉斯琼的生物粘着性组成物
WO2017123744A1 (en) * 2016-01-12 2017-07-20 Grace Therapeutics Llc Betamethasone oral spray formulation and method of use to treat ataxia
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2004270A1 (en) 1988-12-29 1990-06-29 William R. Michael Perfume microcapsules for use in granular detergent compositions
CA2042529C (en) 1990-08-10 2002-07-30 Chokyun Rha Polysaccharide article and uses therefor
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
GB9305593D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
GB9406171D0 (en) * 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
HRP950149A2 (en) 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
GB9414966D0 (en) 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9713980D0 (en) 1997-07-03 1997-09-10 Danbiosyst Uk New conjugates
US20020132803A1 (en) * 2001-01-05 2002-09-19 Mahendra Dedhiya Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
JP2002255795A (ja) * 2001-02-26 2002-09-11 Teijin Ltd 経鼻投与用組成物
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
CN1289085C (zh) * 2002-04-26 2006-12-13 中国人民解放军军事医学科学院毒物药物研究所 鼻腔喷雾剂
CN1332664C (zh) * 2002-04-26 2007-08-22 中国人民解放军军事医学科学院毒物药物研究所 鼻粉剂
GB0329918D0 (en) 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions

Also Published As

Publication number Publication date
CN102389422A (zh) 2012-03-28
NO20062548L (no) 2006-08-15
RS51251B (sr) 2010-12-31
NO335348B1 (no) 2014-11-24
CA2548559A1 (en) 2005-06-23
CN1901905A (zh) 2007-01-24
PT1696911E (pt) 2010-04-29
DE602004026107D1 (de) 2010-04-29
AU2004296586B2 (en) 2010-08-12
CA2548559C (en) 2013-09-03
BRPI0417350A2 (pt) 2009-03-10
EP1696911B1 (en) 2010-03-17
MXPA06006239A (es) 2006-08-23
EP1696911A1 (en) 2006-09-06
JP5103018B2 (ja) 2012-12-19
IL176132A0 (en) 2006-10-05
US7947257B2 (en) 2011-05-24
AU2004296586A2 (en) 2005-06-23
AU2004296586A1 (en) 2005-06-23
WO2005056008A1 (en) 2005-06-23
SI1696911T1 (sl) 2010-06-30
CY1110664T1 (el) 2015-06-10
JP2007513129A (ja) 2007-05-24
GB0328186D0 (en) 2004-01-07
KR20060126532A (ko) 2006-12-07
NZ547848A (en) 2009-04-30
ZA200604553B (en) 2009-09-30
ES2357607T3 (es) 2011-04-28
HRP20100343T1 (hr) 2010-11-30
US20050142073A1 (en) 2005-06-30
KR101194593B1 (ko) 2012-10-25
ATE460932T1 (de) 2010-04-15
ME01070B (me) 2012-10-20
IL176132A (en) 2010-12-30
PL1696911T3 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
NO20062548L (no) Intranasale blandinger
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
MXPA06000675A (es) Derivado de quinolona o sal del mismo.
NO20054244D0 (no) Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
WO2007087431A3 (en) Sublingual fentanyl spray
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
WO2009017837A3 (en) Sublingual fentanyl spray
IL166371A0 (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
TW200716628A (en) Novel compounds
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
TW200733963A (en) Cough inhibitor
WO2005032490A3 (en) Cyclic diamines and derivatives as factor xa inhibitors
EP1362590A8 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
WO2005023188A3 (en) Compounds and methods
TW200510335A (en) Water-soluble phenylpyridazine derivatives and medicines containing the same
WO2004058353A3 (en) Therapeutic use of selective noradrenaline reuptake inhibitors
WO2005023196A3 (en) Compounds and methods